Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CNS Drugs Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Antidepressants
1.2.3 Antipsychotics
1.2.4 Anti-Dementia Drugs
1.2.5 Anti-Parkinson's Drugs
1.2.6 Antiepileptic Drugs
1.2.7 Others
1.3 Market by Application
1.3.1 Global CNS Drugs Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CNS Drugs Market Perspective (2024-2034)
2.2 CNS Drugs Growth Trends by Region
2.2.1 Global CNS Drugs Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 CNS Drugs Historic Market Size by Region (2024-2024)
2.2.3 CNS Drugs Forecasted Market Size by Region (2024-2034)
2.3 CNS Drugs Market Dynamics
2.3.1 CNS Drugs Industry Trends
2.3.2 CNS Drugs Market Drivers
2.3.3 CNS Drugs Market Challenges
2.3.4 CNS Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CNS Drugs Players by Revenue
3.1.1 Global Top CNS Drugs Players by Revenue (2024-2024)
3.1.2 Global CNS Drugs Revenue Market Share by Players (2024-2024)
3.2 Global CNS Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CNS Drugs Revenue
3.4 Global CNS Drugs Market Concentration Ratio
3.4.1 Global CNS Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CNS Drugs Revenue in 2022
3.5 CNS Drugs Key Players Head office and Area Served
3.6 Key Players CNS Drugs Product Solution and Service
3.7 Date of Enter into CNS Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CNS Drugs Breakdown Data by Type
4.1 Global CNS Drugs Historic Market Size by Type (2024-2024)
4.2 Global CNS Drugs Forecasted Market Size by Type (2024-2034)
5 CNS Drugs Breakdown Data by Application
5.1 Global CNS Drugs Historic Market Size by Application (2024-2024)
5.2 Global CNS Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America CNS Drugs Market Size (2024-2034)
6.2 North America CNS Drugs Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America CNS Drugs Market Size by Country (2024-2024)
6.4 North America CNS Drugs Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CNS Drugs Market Size (2024-2034)
7.2 Europe CNS Drugs Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe CNS Drugs Market Size by Country (2024-2024)
7.4 Europe CNS Drugs Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CNS Drugs Market Size (2024-2034)
8.2 Asia-Pacific CNS Drugs Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific CNS Drugs Market Size by Region (2024-2024)
8.4 Asia-Pacific CNS Drugs Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CNS Drugs Market Size (2024-2034)
9.2 Latin America CNS Drugs Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America CNS Drugs Market Size by Country (2024-2024)
9.4 Latin America CNS Drugs Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CNS Drugs Market Size (2024-2034)
10.2 Middle East & Africa CNS Drugs Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa CNS Drugs Market Size by Country (2024-2024)
10.4 Middle East & Africa CNS Drugs Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer CNS Drugs Introduction
11.1.4 Pfizer Revenue in CNS Drugs Business (2024-2024)
11.1.5 Pfizer Recent Development
11.2 Biogen
11.2.1 Biogen Company Detail
11.2.2 Biogen Business Overview
11.2.3 Biogen CNS Drugs Introduction
11.2.4 Biogen Revenue in CNS Drugs Business (2024-2024)
11.2.5 Biogen Recent Development
11.3 Otsuka
11.3.1 Otsuka Company Detail
11.3.2 Otsuka Business Overview
11.3.3 Otsuka CNS Drugs Introduction
11.3.4 Otsuka Revenue in CNS Drugs Business (2024-2024)
11.3.5 Otsuka Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis CNS Drugs Introduction
11.4.4 Novartis Revenue in CNS Drugs Business (2024-2024)
11.4.5 Novartis Recent Development
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Company Detail
11.5.2 Teva Pharmaceutical Business Overview
11.5.3 Teva Pharmaceutical CNS Drugs Introduction
11.5.4 Teva Pharmaceutical Revenue in CNS Drugs Business (2024-2024)
11.5.5 Teva Pharmaceutical Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson CNS Drugs Introduction
11.6.4 Johnson & Johnson Revenue in CNS Drugs Business (2024-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca CNS Drugs Introduction
11.7.4 AstraZeneca Revenue in CNS Drugs Business (2024-2024)
11.7.5 AstraZeneca Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck CNS Drugs Introduction
11.8.4 Merck Revenue in CNS Drugs Business (2024-2024)
11.8.5 Merck Recent Development
11.9 GSK
11.9.1 GSK Company Detail
11.9.2 GSK Business Overview
11.9.3 GSK CNS Drugs Introduction
11.9.4 GSK Revenue in CNS Drugs Business (2024-2024)
11.9.5 GSK Recent Development
11.10 Eli Lilly and Company
11.10.1 Eli Lilly and Company Company Detail
11.10.2 Eli Lilly and Company Business Overview
11.10.3 Eli Lilly and Company CNS Drugs Introduction
11.10.4 Eli Lilly and Company Revenue in CNS Drugs Business (2024-2024)
11.10.5 Eli Lilly and Company Recent Development
11.11 Lundbeck
11.11.1 Lundbeck Company Detail
11.11.2 Lundbeck Business Overview
11.11.3 Lundbeck CNS Drugs Introduction
11.11.4 Lundbeck Revenue in CNS Drugs Business (2024-2024)
11.11.5 Lundbeck Recent Development
11.12 Takeda
11.12.1 Takeda Company Detail
11.12.2 Takeda Business Overview
11.12.3 Takeda CNS Drugs Introduction
11.12.4 Takeda Revenue in CNS Drugs Business (2024-2024)
11.12.5 Takeda Recent Development
11.13 Bristol Myers Squibb
11.13.1 Bristol Myers Squibb Company Detail
11.13.2 Bristol Myers Squibb Business Overview
11.13.3 Bristol Myers Squibb CNS Drugs Introduction
11.13.4 Bristol Myers Squibb Revenue in CNS Drugs Business (2024-2024)
11.13.5 Bristol Myers Squibb Recent Development
11.14 Jiangsu Nhwa Pharmaceutical
11.14.1 Jiangsu Nhwa Pharmaceutical Company Detail
11.14.2 Jiangsu Nhwa Pharmaceutical Business Overview
11.14.3 Jiangsu Nhwa Pharmaceutical CNS Drugs Introduction
11.14.4 Jiangsu Nhwa Pharmaceutical Revenue in CNS Drugs Business (2024-2024)
11.14.5 Jiangsu Nhwa Pharmaceutical Recent Development
11.15 Luye Pharma
11.15.1 Luye Pharma Company Detail
11.15.2 Luye Pharma Business Overview
11.15.3 Luye Pharma CNS Drugs Introduction
11.15.4 Luye Pharma Revenue in CNS Drugs Business (2024-2024)
11.15.5 Luye Pharma Recent Development
11.16 Zhejiang Huahai Pharmaceutical
11.16.1 Zhejiang Huahai Pharmaceutical Company Detail
11.16.2 Zhejiang Huahai Pharmaceutical Business Overview
11.16.3 Zhejiang Huahai Pharmaceutical CNS Drugs Introduction
11.16.4 Zhejiang Huahai Pharmaceutical Revenue in CNS Drugs Business (2024-2024)
11.16.5 Zhejiang Huahai Pharmaceutical Recent Development
11.17 Chengdu Easton Biopharmaceuticals
11.17.1 Chengdu Easton Biopharmaceuticals Company Detail
11.17.2 Chengdu Easton Biopharmaceuticals Business Overview
11.17.3 Chengdu Easton Biopharmaceuticals CNS Drugs Introduction
11.17.4 Chengdu Easton Biopharmaceuticals Revenue in CNS Drugs Business (2024-2024)
11.17.5 Chengdu Easton Biopharmaceuticals Recent Development
11.18 Hansoh Pharmaceutical
11.18.1 Hansoh Pharmaceutical Company Detail
11.18.2 Hansoh Pharmaceutical Business Overview
11.18.3 Hansoh Pharmaceutical CNS Drugs Introduction
11.18.4 Hansoh Pharmaceutical Revenue in CNS Drugs Business (2024-2024)
11.18.5 Hansoh Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CNS Drugs Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Antidepressants
Table 3. Key Players of Antipsychotics
Table 4. Key Players of Anti-Dementia Drugs
Table 5. Key Players of Anti-Parkinson's Drugs
Table 6. Key Players of Antiepileptic Drugs
Table 7. Key Players of Others
Table 8. Global CNS Drugs Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 9. Global CNS Drugs Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 10. Global CNS Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 11. Global CNS Drugs Market Share by Region (2024-2024)
Table 12. Global CNS Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 13. Global CNS Drugs Market Share by Region (2024-2034)
Table 14. CNS Drugs Market Trends
Table 15. CNS Drugs Market Drivers
Table 16. CNS Drugs Market Challenges
Table 17. CNS Drugs Market Restraints
Table 18. Global CNS Drugs Revenue by Players (2024-2024) & (US$ Million)
Table 19. Global CNS Drugs Market Share by Players (2024-2024)
Table 20. Global Top CNS Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CNS Drugs as of 2022)
Table 21. Ranking of Global Top CNS Drugs Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by CNS Drugs Revenue (CR5 and HHI) & (2024-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players CNS Drugs Product Solution and Service
Table 25. Date of Enter into CNS Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global CNS Drugs Market Size by Type (2024-2024) & (US$ Million)
Table 28. Global CNS Drugs Revenue Market Share by Type (2024-2024)
Table 29. Global CNS Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 30. Global CNS Drugs Revenue Market Share by Type (2024-2034)
Table 31. Global CNS Drugs Market Size by Application (2024-2024) & (US$ Million)
Table 32. Global CNS Drugs Revenue Market Share by Application (2024-2024)
Table 33. Global CNS Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 34. Global CNS Drugs Revenue Market Share by Application (2024-2034)
Table 35. North America CNS Drugs Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 36. North America CNS Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 37. North America CNS Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 38. Europe CNS Drugs Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 39. Europe CNS Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 40. Europe CNS Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 41. Asia-Pacific CNS Drugs Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 42. Asia-Pacific CNS Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 43. Asia-Pacific CNS Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 44. Latin America CNS Drugs Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 45. Latin America CNS Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 46. Latin America CNS Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 47. Middle East & Africa CNS Drugs Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 48. Middle East & Africa CNS Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa CNS Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 50. Pfizer Company Detail
Table 51. Pfizer Business Overview
Table 52. Pfizer CNS Drugs Product
Table 53. Pfizer Revenue in CNS Drugs Business (2024-2024) & (US$ Million)
Table 54. Pfizer Recent Development
Table 55. Biogen Company Detail
Table 56. Biogen Business Overview
Table 57. Biogen CNS Drugs Product
Table 58. Biogen Revenue in CNS Drugs Business (2024-2024) & (US$ Million)
Table 59. Biogen Recent Development
Table 60. Otsuka Company Detail
Table 61. Otsuka Business Overview
Table 62. Otsuka CNS Drugs Product
Table 63. Otsuka Revenue in CNS Drugs Business (2024-2024) & (US$ Million)
Table 64. Otsuka Recent Development
Table 65. Novartis Company Detail
Table 66. Novartis Business Overview
Table 67. Novartis CNS Drugs Product
Table 68. Novartis Revenue in CNS Drugs Business (2024-2024) & (US$ Million)
Table 69. Novartis Recent Development
Table 70. Teva Pharmaceutical Company Detail
Table 71. Teva Pharmaceutical Business Overview
Table 72. Teva Pharmaceutical CNS Drugs Product
Table 73. Teva Pharmaceutical Revenue in CNS Drugs Business (2024-2024) & (US$ Million)
Table 74. Teva Pharmaceutical Recent Development
Table 75. Johnson & Johnson Company Detail
Table 76. Johnson & Johnson Business Overview
Table 77. Johnson & Johnson CNS Drugs Product
Table 78. Johnson & Johnson Revenue in CNS Drugs Business (2024-2024) & (US$ Million)
Table 79. Johnson & Johnson Recent Development
Table 80. AstraZeneca Company Detail
Table 81. AstraZeneca Business Overview
Table 82. AstraZeneca CNS Drugs Product
Table 83. AstraZeneca Revenue in CNS Drugs Business (2024-2024) & (US$ Million)
Table 84. AstraZeneca Recent Development
Table 85. Merck Company Detail
Table 86. Merck Business Overview
Table 87. Merck CNS Drugs Product
Table 88. Merck Revenue in CNS Drugs Business (2024-2024) & (US$ Million)
Table 89. Merck Recent Development
Table 90. GSK Company Detail
Table 91. GSK Business Overview
Table 92. GSK CNS Drugs Product
Table 93. GSK Revenue in CNS Drugs Business (2024-2024) & (US$ Million)
Table 94. GSK Recent Development
Table 95. Eli Lilly and Company Company Detail
Table 96. Eli Lilly and Company Business Overview
Table 97. Eli Lilly and Company CNS Drugs Product
Table 98. Eli Lilly and Company Revenue in CNS Drugs Business (2024-2024) & (US$ Million)
Table 99. Eli Lilly and Company Recent Development
Table 100. Lundbeck Company Detail
Table 101. Lundbeck Business Overview
Table 102. Lundbeck CNS Drugs Product
Table 103. Lundbeck Revenue in CNS Drugs Business (2024-2024) & (US$ Million)
Table 104. Lundbeck Recent Development
Table 105. Takeda Company Detail
Table 106. Takeda Business Overview
Table 107. Takeda CNS Drugs Product
Table 108. Takeda Revenue in CNS Drugs Business (2024-2024) & (US$ Million)
Table 109. Takeda Recent Development
Table 110. Bristol Myers Squibb Company Detail
Table 111. Bristol Myers Squibb Business Overview
Table 112. Bristol Myers Squibb CNS Drugs Product
Table 113. Bristol Myers Squibb Revenue in CNS Drugs Business (2024-2024) & (US$ Million)
Table 114. Bristol Myers Squibb Recent Development
Table 115. Jiangsu Nhwa Pharmaceutical Company Detail
Table 116. Jiangsu Nhwa Pharmaceutical Business Overview
Table 117. Jiangsu Nhwa Pharmaceutical CNS Drugs Product
Table 118. Jiangsu Nhwa Pharmaceutical Revenue in CNS Drugs Business (2024-2024) & (US$ Million)
Table 119. Jiangsu Nhwa Pharmaceutical Recent Development
Table 120. Luye Pharma Company Detail
Table 121. Luye Pharma Business Overview
Table 122. Luye Pharma CNS Drugs Product
Table 123. Luye Pharma Revenue in CNS Drugs Business (2024-2024) & (US$ Million)
Table 124. Luye Pharma Recent Development
Table 125. Zhejiang Huahai Pharmaceutical Company Detail
Table 126. Zhejiang Huahai Pharmaceutical Business Overview
Table 127. Zhejiang Huahai Pharmaceutical CNS Drugs Product
Table 128. Zhejiang Huahai Pharmaceutical Revenue in CNS Drugs Business (2024-2024) & (US$ Million)
Table 129. Zhejiang Huahai Pharmaceutical Recent Development
Table 130. Chengdu Easton Biopharmaceuticals Company Detail
Table 131. Chengdu Easton Biopharmaceuticals Business Overview
Table 132. Chengdu Easton Biopharmaceuticals CNS Drugs Product
Table 133. Chengdu Easton Biopharmaceuticals Revenue in CNS Drugs Business (2024-2024) & (US$ Million)
Table 134. Chengdu Easton Biopharmaceuticals Recent Development
Table 135. Hansoh Pharmaceutical Company Detail
Table 136. Hansoh Pharmaceutical Business Overview
Table 137. Hansoh Pharmaceutical CNS Drugs Product
Table 138. Hansoh Pharmaceutical Revenue in CNS Drugs Business (2024-2024) & (US$ Million)
Table 139. Hansoh Pharmaceutical Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CNS Drugs Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global CNS Drugs Market Share by Type: 2022 VS 2034
Figure 3. Antidepressants Features
Figure 4. Antipsychotics Features
Figure 5. Anti-Dementia Drugs Features
Figure 6. Anti-Parkinson's Drugs Features
Figure 7. Antiepileptic Drugs Features
Figure 8. Others Features
Figure 9. Global CNS Drugs Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global CNS Drugs Market Share by Application: 2022 VS 2034
Figure 11. Hospital and Clinic Case Studies
Figure 12. Pharmacy Case Studies
Figure 13. CNS Drugs Report Years Considered
Figure 14. Global CNS Drugs Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 15. Global CNS Drugs Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 16. Global CNS Drugs Market Share by Region: 2022 VS 2034
Figure 17. Global CNS Drugs Market Share by Players in 2022
Figure 18. Global Top CNS Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CNS Drugs as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by CNS Drugs Revenue in 2022
Figure 20. North America CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 21. North America CNS Drugs Market Share by Country (2024-2034)
Figure 22. United States CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 23. Canada CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. Europe CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 25. Europe CNS Drugs Market Share by Country (2024-2034)
Figure 26. Germany CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. France CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. U.K. CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Italy CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. Russia CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. Nordic Countries CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. Asia-Pacific CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 33. Asia-Pacific CNS Drugs Market Share by Region (2024-2034)
Figure 34. China CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. Japan CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. South Korea CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. Southeast Asia CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. India CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 39. Australia CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. Latin America CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 41. Latin America CNS Drugs Market Share by Country (2024-2034)
Figure 42. Mexico CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 43. Brazil CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Middle East & Africa CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 45. Middle East & Africa CNS Drugs Market Share by Country (2024-2034)
Figure 46. Turkey CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 47. Saudi Arabia CNS Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in CNS Drugs Business (2024-2024)
Figure 49. Biogen Revenue Growth Rate in CNS Drugs Business (2024-2024)
Figure 50. Otsuka Revenue Growth Rate in CNS Drugs Business (2024-2024)
Figure 51. Novartis Revenue Growth Rate in CNS Drugs Business (2024-2024)
Figure 52. Teva Pharmaceutical Revenue Growth Rate in CNS Drugs Business (2024-2024)
Figure 53. Johnson & Johnson Revenue Growth Rate in CNS Drugs Business (2024-2024)
Figure 54. AstraZeneca Revenue Growth Rate in CNS Drugs Business (2024-2024)
Figure 55. Merck Revenue Growth Rate in CNS Drugs Business (2024-2024)
Figure 56. GSK Revenue Growth Rate in CNS Drugs Business (2024-2024)
Figure 57. Eli Lilly and Company Revenue Growth Rate in CNS Drugs Business (2024-2024)
Figure 58. Lundbeck Revenue Growth Rate in CNS Drugs Business (2024-2024)
Figure 59. Takeda Revenue Growth Rate in CNS Drugs Business (2024-2024)
Figure 60. Bristol Myers Squibb Revenue Growth Rate in CNS Drugs Business (2024-2024)
Figure 61. Jiangsu Nhwa Pharmaceutical Revenue Growth Rate in CNS Drugs Business (2024-2024)
Figure 62. Luye Pharma Revenue Growth Rate in CNS Drugs Business (2024-2024)
Figure 63. Zhejiang Huahai Pharmaceutical Revenue Growth Rate in CNS Drugs Business (2024-2024)
Figure 64. Chengdu Easton Biopharmaceuticals Revenue Growth Rate in CNS Drugs Business (2024-2024)
Figure 65. Hansoh Pharmaceutical Revenue Growth Rate in CNS Drugs Business (2024-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed